These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 31937612)
1. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor. Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612 [TBL] [Abstract][Full Text] [Related]
2. CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer. Yang Y; Jiang D; Zhou Z; Xiong H; Yang X; Peng G; Xia W; Wang S; Lei H; Zhao J; Qian Z; Wu S; Pang J Cell Oncol (Dordr); 2021 Aug; 44(4):871-887. PubMed ID: 33905040 [TBL] [Abstract][Full Text] [Related]
3. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204 [TBL] [Abstract][Full Text] [Related]
4. The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma. Wu D; Yin H; Yang C; Zhang Z; Fang F; Wang J; Li X; Xie Y; Hu X; Zhuo R; Chen Y; Yu J; Li T; Li G; Pan J BMC Cancer; 2024 Aug; 24(1):928. PubMed ID: 39090568 [TBL] [Abstract][Full Text] [Related]
5. Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome. Wei Y; Li C; Bian H; Qian W; Jin K; Xu T; Guo X; Lu X; Su F Mol Cancer; 2021 Jan; 20(1):5. PubMed ID: 33397398 [TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits the proliferation and migration of osteosarcoma by regulating the expression of super Ouyang Z; Zhu H; Liu Z; Tu C; Qu J; Lu Q; Xu M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 49(4):541-552. PubMed ID: 39019783 [TBL] [Abstract][Full Text] [Related]
7. Identification of key genes in osteosarcoma - before and after CDK7 treatment. An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127 [TBL] [Abstract][Full Text] [Related]
8. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma. Cao X; Dang L; Zheng X; Lu Y; Lu Y; Ji R; Zhang T; Ruan X; Zhi J; Hou X; Yi X; Li MJ; Gu T; Gao M; Zhang L; Chen Y Thyroid; 2019 Jun; 29(6):809-823. PubMed ID: 30924726 [No Abstract] [Full Text] [Related]
9. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Jiang YY; Lin DC; Mayakonda A; Hazawa M; Ding LW; Chien WW; Xu L; Chen Y; Xiao JF; Senapedis W; Baloglu E; Kanojia D; Shang L; Xu X; Yang H; Tyner JW; Wang MR; Koeffler HP Gut; 2017 Aug; 66(8):1358-1368. PubMed ID: 27196599 [TBL] [Abstract][Full Text] [Related]
10. Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7. Hu S; Marineau JJ; Rajagopal N; Hamman KB; Choi YJ; Schmidt DR; Ke N; Johannessen L; Bradley MJ; Orlando DA; Alnemy SR; Ren Y; Ciblat S; Winter DK; Kabro A; Sprott KT; Hodgson JG; Fritz CC; Carulli JP; di Tomaso E; Olson ER Cancer Res; 2019 Jul; 79(13):3479-3491. PubMed ID: 31064851 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. Nagaraja S; Vitanza NA; Woo PJ; Taylor KR; Liu F; Zhang L; Li M; Meng W; Ponnuswami A; Sun W; Ma J; Hulleman E; Swigut T; Wysocka J; Tang Y; Monje M Cancer Cell; 2017 May; 31(5):635-652.e6. PubMed ID: 28434841 [TBL] [Abstract][Full Text] [Related]
12. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Wong RWJ; Ngoc PCT; Leong WZ; Yam AWY; Zhang T; Asamitsu K; Iida S; Okamoto T; Ueda R; Gray NS; Ishida T; Sanda T Blood; 2017 Nov; 130(21):2326-2338. PubMed ID: 28978570 [TBL] [Abstract][Full Text] [Related]
13. CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer. Wang J; Zhang R; Lin Z; Zhang S; Chen Y; Tang J; Hong J; Zhou X; Zong Y; Xu Y; Meng R; Xu S; Liu L; Zhang T; Yang K; Dong X; Wu G J Hematol Oncol; 2020 Jul; 13(1):99. PubMed ID: 32690037 [TBL] [Abstract][Full Text] [Related]
14. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study. Shi CS; Kuo KL; Chen MS; Chow PM; Liu SH; Chang YW; Lin WC; Liao SM; Hsu CH; Hsu FS; Chang HC; Huang KH Cells; 2019 Nov; 8(11):. PubMed ID: 31752390 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin-dependent kinase 7 suppresses human hepatocellular carcinoma by inducing apoptosis. Zhong L; Yang S; Jia Y; Lei K J Cell Biochem; 2018 Dec; 119(12):9742-9751. PubMed ID: 30145799 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Sun B; Mason S; Wilson RC; Hazard SE; Wang Y; Fang R; Wang Q; Yeh ES; Yang M; Roberts TM; Zhao JJ; Wang Q Oncogene; 2020 Jan; 39(1):50-63. PubMed ID: 31462705 [TBL] [Abstract][Full Text] [Related]
17. THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer. Lu P; Geng J; Zhang L; Wang Y; Niu N; Fang Y; Liu F; Shi J; Zhang ZG; Sun YW; Wang LW; Tang Y; Xue J Oncogene; 2019 May; 38(20):3932-3945. PubMed ID: 30692639 [TBL] [Abstract][Full Text] [Related]
18. THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours. Sun J; Zhang Q; Sun X; Xue A; Gao X; Shen K Cell Commun Signal; 2022 Sep; 20(1):138. PubMed ID: 36076237 [TBL] [Abstract][Full Text] [Related]
19. Combinational therapeutic targeting of BRD4 and CDK7 synergistically induces anticancer effects in head and neck squamous cell carcinoma. Zhang W; Ge H; Jiang Y; Huang R; Wu Y; Wang D; Guo S; Li S; Wang Y; Jiang H; Cheng J Cancer Lett; 2020 Jan; 469():510-523. PubMed ID: 31765738 [TBL] [Abstract][Full Text] [Related]
20. CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263. Huang T; Ding X; Xu G; Chen G; Cao Y; Peng C; Shen S; Lv Y; Wang L; Zou X Cell Death Dis; 2019 Aug; 10(8):602. PubMed ID: 31399555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]